| (Values in U.S. Thousands) | Dec, 2017 | Dec, 2016 | Dec, 2015 | Dec, 2014 | Dec, 2013 |
| Sales | 6,810 | 9,240 | 9,890 | 10,980 | 20 |
| Sales Growth | -26.30% | -6.57% | -9.93% | +54,800.00% | -90.00% |
| Net Income | -6,810 | -2,160 | -860 | -700 | -920 |
| Net Income Growth | -215.28% | -151.16% | -22.86% | +23.91% | +39.07% |
Medite Cancer Diagnostics Inc (MDIT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Medite Cancer Diagnostics Inc is involved in the development, manufacture and distribution of medical laboratory automation equipment and supplies for anatomic pathology, histology and cytology. Medite Cancer Diagnostics Inc, formerly known as CytoCore Inc., is based in Orlando, Florida.
Fiscal Year End Date: 12/31